Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 3
2012 4
2013 7
2014 5
2015 6
2016 8
2017 5
2018 8
2019 7
2020 12
2021 17
2022 10
2023 14
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.
Falkenbach F, Ambrosini F, Tennstedt P, Eiber M, Heck MM, Preisser F, Graefen M, Budäus L, Koehler D, Knipper S, Maurer T. Falkenbach F, et al. Among authors: heck mm. Cancers (Basel). 2023 Oct 16;15(20):5008. doi: 10.3390/cancers15205008. Cancers (Basel). 2023. PMID: 37894375 Free PMC article.
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
Falkenbach F, Knipper S, Koehler D, Ambrosini F, Steuber T, Graefen M, Budäus L, Eiber M, Lunger L, Lischewski F, Heck MM, Maurer T. Falkenbach F, et al. Among authors: heck mm. World J Urol. 2023 Sep;41(9):2343-2350. doi: 10.1007/s00345-023-04534-5. Epub 2023 Jul 29. World J Urol. 2023. PMID: 37515651 Free PMC article.
The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy.
Karimzadeh A, Heck M, Tauber R, Solaris E, Nekolla S, Knorr K, Haller B, D'Alessandria C, Weber WA, Eiber M, Rauscher I. Karimzadeh A, et al. Among authors: heck m. J Nucl Med. 2023 Aug;64(8):1252-1258. doi: 10.2967/jnumed.122.265346. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290796 Clinical Trial.
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
Muehlematter UJ, Schweiger L, Ferraro DA, Hermanns T, Maurer T, Heck MM, Rupp NJ, Eiber M, Rauscher I, Burger IA. Muehlematter UJ, et al. Among authors: heck mm. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3137-3146. doi: 10.1007/s00259-023-06278-1. Epub 2023 Jun 1. Eur J Nucl Med Mol Imaging. 2023. PMID: 37261472 Free PMC article.
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
Meagher MF, Mir MC, Minervini A, Kriegmair M, Heck M, Porpiglia F, Van Bruwaene S, Linares E, Hevia V, D'Anna M, Veccia A, Roussel E, Claps F, Palumbo C, Marchioni M, Afari J, Saitta C, Liu F, Rubio J, Campi R, Mari A, Amiel T, Checcucci E, Musquera M, Guruli G, Pavan N, Albersen M, Antonelli A, Klatte T, Autorino R, McKay RR, Derweesh IH. Meagher MF, et al. Among authors: heck m. Front Oncol. 2023 Mar 29;13:1113246. doi: 10.3389/fonc.2023.1113246. eCollection 2023. Front Oncol. 2023. PMID: 37064092 Free PMC article.
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).
Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, Giesel FL, Reiter R, Maurer T, Heck M, Gafita A, Morris MJ, Fanti S, Weber WA, Hope TA, Hofman MS, Fendler WP, Eiber M. Seifert R, et al. Among authors: heck m. Eur Urol. 2023 May;83(5):405-412. doi: 10.1016/j.eururo.2023.02.002. Epub 2023 Mar 17. Eur Urol. 2023. PMID: 36935345 Free article. Review.
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study.
Groeben C, Boehm K, Koch R, Sonntag U, Nestler T, Struck J, Heck M, Baunacke M, Uhlig A, Koelker M, Meyer CP, Becker B, Salem J, Huber J, Leitsmann M. Groeben C, et al. Among authors: heck m. World J Urol. 2023 Feb;41(2):601-609. doi: 10.1007/s00345-022-04271-1. Epub 2023 Jan 12. World J Urol. 2023. PMID: 36633651 Free PMC article.
Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases.
Lunger L, Steinhelfer L, Korn P, Eiber M, Maurer T, Büchler J, Horn T, Gschwend JE, Heck MM. Lunger L, et al. Among authors: heck mm. Eur Urol Oncol. 2023 Feb;6(1):95-98. doi: 10.1016/j.euo.2022.12.001. Epub 2023 Jan 4. Eur Urol Oncol. 2023. PMID: 36604297
78 results